Lower limb bypass

10 min read Last updated April 9, 2026

Surgical approach

  • Indications: critical limb-threatening ischaemia (rest pain, tissue loss), severe lifestyle-limiting claudication, acute-on-chronic ischaemia (selected cases)
    • Common operations: femoral–popliteal bypass (above/below knee), femoral–distal (tibial/pedal) bypass, aorto-bifemoral bypass, femoro-femoral crossover, axillo-femoral bypass
  • Conduit choice: autologous vein (long saphenous) preferred for distal targets, prosthetic graft (PTFE/Dacron) often for above-knee fem-pop or extra-anatomical
    • Vein harvest may be open or endoscopic, adds time and additional wound/pain sites
  • Exposure and anastomoses
    • Proximal control at common femoral artery (groin incision), distal target at popliteal/tibial/pedal artery (knee/calf/ankle/foot incisions)
    • Systemic heparinisation before clamping, arteriotomy and end-to-side anastomoses, clamp release and haemostasis
    • Completion assessment: Doppler signals, flow probe, completion angiography (variable)
  • Aorto-iliac reconstructions (if performed): midline laparotomy/retroperitoneal approach for aorto-bifemoral, higher physiological stress and blood loss than infra-inguinal bypass
    • Extra-anatomical (axillo-femoral/fem-fem): used in hostile abdomen/high risk, often less invasive but still significant comorbidity burden

Anaesthetic management

  • Type of anaesthesia: GA or regional (neuraxial/PNB) depending on level of bypass, anticoagulation plan, patient factors and local expertise
    • Infra-inguinal bypass: GA common, alternatives include CSE/spinal (if anticoagulation timing allows) or combined GA + peripheral blocks for analgesia
    • Aorto-bifemoral: GA with ETT almost always
  • Airway: ETT usually preferred (length, physiological swings, need for controlled ventilation, potential major haemorrhage), SGA only in carefully selected short, stable infra-inguinal cases
    • Consider aspiration risk (opioids, diabetes gastroparesis, bowel obstruction unlikely but aorto surgery/laparotomy increases risk)
  • Duration: fem-pop 2–4 h, fem-distal 3–6 h, aorto-bifemoral 3–6+ h, add time for vein harvest and difficult distal targets
    • Plan for prolonged immobility/pressure area care and temperature management
  • How painful: moderate–severe (multiple incisions, groin + distal + vein harvest), aorto-bifemoral severe (laparotomy + groins)
    • Analgesia strategy: multimodal + regional where safe, consider catheter techniques for prolonged analgesia
  • Monitoring and access: 2 large-bore IV, arterial line (common), consider central access if major blood loss/vasoactive infusions anticipated, urinary catheter for longer cases
    • Temperature monitoring and active warming, frequent glucose checks in diabetics
  • Key intra-op priorities: maintain perfusion pressure, avoid tachycardia/ischaemia, manage anticoagulation (heparin/protamine), anticipate blood loss, preserve graft flow (avoid severe hypotension/vasospasm)
    • Vasoactive support: noradrenaline commonly used to maintain MAP without excessive tachycardia, treat hypovolaemia first

Patient profile and comorbidity

  • Peripheral arterial disease is a marker of systemic atherosclerosis
    • High prevalence of IHD, heart failure, cerebrovascular disease, CKD, diabetes, COPD, smoking, frailty and malnutrition
  • Medication issues
    • Antiplatelets: aspirin usually continued, clopidogrel often continued for vascular indications but impacts neuraxial decisions
    • Anticoagulants: DOAC/warfarin management per local policy, bridging occasionally, impacts regional techniques
    • Statins and beta-blockers: continue, avoid initiating high-dose beta-blocker immediately pre-op unless strong indication and time for titration
  • Functional status and limb status
    • Rest pain/opioid tolerance, infected ulcers/osteomyelitis, sepsis risk, anaemia of chronic disease

Preoperative assessment and optimisation

  • Cardiovascular risk assessment
    • Identify active cardiac conditions (unstable angina, decompensated HF, significant arrhythmia, severe valvular disease) and optimise/seek cardiology input if time allows
    • Baseline ECG, echo if murmur/HF symptoms/poor functional capacity with suspected structural disease
  • Baseline bloods and transfusion planning
    • FBC (anaemia common), U&amp,E (CKD), coagulation (anticoagulants), group &amp, save/crossmatch depending on procedure (higher for aorto-bifemoral)
  • Infection and sepsis
    • Ulcer infection/osteomyelitis: antibiotics, lactate, cultures, consider source control timing, higher vasopressor requirement risk
  • Renal protection
    • Avoid dehydration, rationalise nephrotoxins, anticipate contrast exposure (pre-op imaging/intra-op angiography)
  • Consent and planning for postoperative destination
    • HDU/ICU for aorto-bifemoral, significant comorbidity, sepsis, major blood loss risk, or need for vasoactive support

Intraoperative anaesthetic technique

  • General anaesthesia
    • Induction: avoid hypotension/tachycardia, consider etomidate/ketamine in severe LV dysfunction or sepsis, opioid and vasopressor boluses as needed
    • Maintenance: volatile or TIVA, aim normocapnia, normothermia, avoid excessive vasodilation that jeopardises graft flow
  • Regional/neuraxial options (when appropriate)
    • Spinal/CSE: can provide stable anaesthesia for infra-inguinal surgery but sympathetic block may cause hypotension, must align with antiplatelet/anticoagulant status and intra-op heparin timing
    • Peripheral blocks for analgesia: fascia iliaca/femoral + sciatic (popliteal) ± obturator, adductor canal + sciatic may reduce quadriceps weakness, consider wound sites (groin + distal + harvest)
    • Continuous catheters (fascia iliaca/adductor canal/popliteal sciatic) can reduce opioids, balance against anticoagulation and compartment syndrome masking concerns
  • Anticoagulation and haemostasis
    • Systemic heparin typically 50–100 IU/kg before clamping (local practice varies), check ACT if used, communicate timing for neuraxial catheter removal
    • Protamine reversal may be partial/complete depending on bleeding vs thrombosis risk, watch for hypotension, pulmonary hypertension, anaphylactoid reactions (higher risk with prior exposure, NPH insulin, fish allergy)
  • Haemodynamic targets
    • Maintain coronary perfusion and graft flow: avoid sustained hypotension, common target MAP ≥ 65–75 mmHg, higher if chronic hypertension/critical limb perfusion concerns (individualise)
    • Treat causes: bleeding/hypovolaemia, vasodilation, myocardial ischaemia, arrhythmia, use noradrenaline early if vasoplegia with adequate volume
  • Fluids and blood
    • Balance: avoid hypovolaemia (graft thrombosis, AKI) and overload (cardiac failure, pulmonary oedema)
    • Blood loss: variable, can be significant with redo groins, aorto surgery, difficult dissection, have blood available as planned
  • Tourniquet: not typically used for bypass, if used for adjunct procedures, manage tourniquet physiology and analgesia

Analgesia

  • Multimodal baseline
    • Paracetamol, NSAID/COX-2 if renal function and bleeding risk acceptable, consider gabapentinoids cautiously (sedation/falls) and avoid routine use in frail elderly
  • Opioids
    • Often opioid-tolerant due to rest pain, plan PCA (morphine/oxycodone) with antiemetic and bowel regimen, consider ketamine infusion for opioid-sparing in tolerant patients
  • Regional analgesia options
    • Adductor canal + sciatic (popliteal) for below-knee targets, fascia iliaca/femoral for groin/upper thigh, local infiltration by surgeon at incisions
    • Epidural: may be used for aorto-bifemoral in some centres (excellent analgesia) but requires meticulous anticoagulation coordination and haemodynamic management

Postoperative care

  • Graft surveillance and limb assessment
    • Regular neurovascular observations: pain, pallor, pulselessness, paraesthesia, paralysis, temperature, Doppler signals, escalating analgesic requirement can be a sign of ischaemia/compartment syndrome
  • Haemodynamic and respiratory care
    • Maintain MAP to support graft and renal perfusion, manage fluids/diuresis, treat myocardial ischaemia early
  • Antithrombotic therapy
    • Post-op antiplatelet/anticoagulation per surgeon/vascular protocol, coordinate with any neuraxial/PNB catheters and removal timing
  • Complications to anticipate
    • Cardiac: MI, arrhythmia, heart failure, Renal: AKI, Respiratory: atelectasis/pneumonia, Wound: infection/lymph leak, Graft: thrombosis/bleeding

Test yourself…

You are asked to anaesthetise a 72-year-old with diabetes, CKD3 and IHD for femoro-popliteal bypass. What are your key preoperative concerns and how will you optimise them?

Structure: comorbidities → investigations → optimisation → planning level of care.

  • Cardiac risk: PAD implies high IHD burden, assess symptoms (angina, dyspnoea), functional capacity, prior stents/CABG, heart failure history
    • Investigations: ECG, troponin only if symptomatic/concern, echo if murmur/HF symptoms, consider peri-op BNP/NT-proBNP if used locally for risk stratification
  • Renal: baseline creatinine/eGFR, electrolytes, avoid dehydration, review nephrotoxins, anticipate contrast exposure
  • Diabetes: glucose control plan, adjust insulin/oral agents, consider gastroparesis/aspiration risk, infection risk
  • Anaemia/infection: check FBC, CRP if infected ulcers, treat sepsis, crossmatch as appropriate
  • Medication optimisation: continue statin, beta-blocker (if established), aspirin, clarify clopidogrel/DOAC/warfarin plan, document last doses
  • Plan postoperative destination: consider HDU if significant IHD/HF/CKD, sepsis, anticipated vasoactive support or major blood loss
Discuss your choice of anaesthetic technique for infra-inguinal bypass. Compare GA vs neuraxial vs peripheral nerve blocks.

Examiners expect: patient/surgery factors, anticoagulation constraints, haemodynamic effects, analgesia quality, practicalities.

  • GA: reliable for long cases and multiple incisions, easier control of ventilation/CO2/temperature, facilitates urgent conversion/bleeding control
    • Risks: hypotension from induction/volatile, myocardial ischaemia, higher opioid requirement if no regional
  • Neuraxial (spinal/CSE/epidural): excellent anaesthesia/analgesia, may reduce stress response, but sympathetic block can cause hypotension jeopardising coronary and limb perfusion
    • Major limitation: antiplatelets/anticoagulants and intra-op heparinisation, must comply with local/ASRA/RA-UK guidance and timing for catheter removal
  • Peripheral nerve blocks: useful adjunct for analgesia (adductor canal/femoral + sciatic), less sympathectomy than neuraxial, can reduce opioids and facilitate early mobilisation
    • Cautions: motor weakness (falls), local anaesthetic systemic toxicity risk (large volumes), anticoagulation considerations for deep blocks, and potential to obscure evolving compartment syndrome (clinical vigilance required)
  • Pragmatic approach: GA + targeted PNB/local infiltration is common, neuraxial reserved for selected patients with acceptable coagulation status and robust haemodynamic plan
What monitoring and vascular access would you use for femoro-distal bypass and why?

Tailor to comorbidity, expected blood loss, and need for tight BP control.

  • Standard monitoring + temperature, capnography if sedated/GA
  • Arterial line: beat-to-beat BP for graft perfusion targets, rapid detection of bleeding, frequent ABGs/glucose/electrolytes
  • IV access: two wide-bore cannulae, consider rapid infuser availability if redo/bleeding risk
  • Central venous access: not routine, consider if poor peripheral access, need for vasoactive infusions, severe cardiac disease, or major surgery (aorto-bifemoral)
  • Urinary catheter: long cases, CKD, expected fluid shifts, aorto surgery
How do you manage intraoperative hypotension during lower limb bypass?

Aim: restore perfusion pressure without provoking tachycardia/ischaemia, treat cause not just numbers.

  • Immediate actions: check surgical field for bleeding, confirm BP reading (arterial line damping), assess depth of anaesthesia, ECG for ischaemia/arrhythmia
  • Volume status: give fluid bolus if hypovolaemia likely, send Hb/ABG, transfuse if significant blood loss/anaemia with ischaemia risk
  • Vasopressors: metaraminol/phenylephrine boluses for transient vasodilation, noradrenaline infusion for persistent vasoplegia (common in sepsis/volatile anaesthesia)
    • Avoid excessive pure alpha vasoconstriction if concern about peripheral vasospasm, prioritise adequate MAP and cardiac output
  • Inotropes: consider if low cardiac output (echo/clinical) e.g. dobutamine, treat myocardial ischaemia (oxygenation, analgesia, BP, rate control, GTN if hypertensive/ischaemic)
Explain the perioperative management of heparin and protamine for bypass surgery. What complications can occur?

Focus: timing, monitoring, and adverse effects.

  • Heparin: given before arterial clamping/anastomosis, dose often 50–100 IU/kg, may monitor ACT depending on centre/procedure complexity
  • Protamine: used to reverse heparin partially or fully if bleeding risk, dose guided by heparin dose/time/ACT
  • Protamine adverse effects: hypotension (rapid administration), anaphylactoid reactions, pulmonary hypertension/right heart failure, bradycardia
    • Higher risk groups: previous protamine exposure, NPH insulin use, vasectomy, fish allergy (association described, assess history pragmatically)
  • Thrombosis vs bleeding: over-reversal may increase graft thrombosis risk, under-reversal may increase bleeding/haematoma risk
A patient becomes increasingly acidotic and hyperkalaemic near the end of a prolonged femoro-distal bypass. What are the likely causes and your management?

Think: transfusion, renal impairment, tissue ischaemia/reperfusion, sepsis, hypoventilation.

  • Causes: AKI/CKD with reduced K excretion, transfusion-related hyperkalaemia (older blood, rapid transfusion), metabolic acidosis from hypoperfusion/sepsis, reperfusion of ischaemic limb, hypoventilation causing respiratory acidosis
  • Assess: ABG (pH, K, lactate), ECG changes, urine output, haemodynamics, temperature, transfusion history
  • Treat hyperkalaemia: calcium chloride/gluconate if ECG changes, insulin-dextrose, nebulised salbutamol, consider sodium bicarbonate if severe acidaemia, optimise ventilation and perfusion
  • Definitive: stop K sources, consider furosemide if appropriate, renal replacement therapy if refractory/severe with renal failure, involve ICU early
Postoperatively the patient has severe calf pain, pain on passive stretch and tense swelling after tibial bypass. What is the diagnosis and immediate management?

This is a limb-threatening emergency.

  • Diagnosis: acute compartment syndrome (may occur after revascularisation/reperfusion, can coexist with graft occlusion)
  • Immediate actions: urgent surgical review, do not delay for imaging, remove constrictive dressings, keep limb at heart level (not elevated excessively), optimise perfusion pressure and oxygenation
  • Analgesia: treat pain but avoid masking progression, regional techniques can complicate assessment—ensure heightened surveillance if blocks/catheters used
  • Definitive management: urgent fasciotomy
How would you manage antiplatelet therapy in a patient listed for lower limb bypass, and how does this affect neuraxial anaesthesia?

Answer should reference balancing thrombosis risk vs neuraxial haematoma risk and following local/national guidance.

  • Aspirin: commonly continued for vascular surgery, generally compatible with neuraxial techniques as sole agent (per guidance)
  • Clopidogrel/prasugrel/ticagrelor: often continued for vascular indications but typically contraindicate neuraxial block unless stopped for an appropriate interval and platelet function recovered (follow local/RA-UK/ASRA guidance)
  • Intra-op heparinisation: neuraxial catheter placement/removal must be timed around heparin dosing, avoid traumatic insertion, document timing meticulously
  • If neuraxial not feasible: choose GA with peripheral blocks/local infiltration for analgesia, consider superficial blocks with safer bleeding profile where appropriate
Describe the causes, recognition and management of perioperative myocardial infarction in a patient undergoing lower limb bypass.

FRCA themes: demand ischaemia, silent MI, haemodynamic management, postoperative monitoring.

  • Causes: supply-demand mismatch (anaemia, hypotension, tachycardia, hypoxia) and plaque rupture (less common but important)
  • Recognition: may be silent under anaesthesia, ECG changes, haemodynamic instability, new arrhythmia, rising troponin post-op, pulmonary oedema
  • Immediate management: ABCs, treat hypoxia, correct hypotension (fluids/vasopressors), control heart rate, treat pain, correct anaemia, consider GTN if hypertensive/ischaemic, early cardiology/ICU involvement
  • Ongoing: postoperative ECG/troponin surveillance in high-risk patients per local pathways, optimise secondary prevention (statin, antiplatelet, beta-blocker if appropriate)

0 comments